Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02303028
Title Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid and CNS Tumours
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Hospital for Sick Children
Indications

Advanced Solid Tumor

rhabdomyosarcoma

neuroblastoma

central nervous system cancer

Therapies

Pazopanib + Topotecan

Age Groups: child
Covered Countries CAN


No variant requirements are available.